These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 27416681)
1. [INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)]. Trashkov AP; Vasil'ev AG; Kovalenko AL; Petrov AY; Valeev VV Eksp Klin Farmakol; 2016; 79(2):34-9. PubMed ID: 27416681 [TBL] [Abstract][Full Text] [Related]
2. Proliferation of Walker 256 carcinosarcoma cells: effect of whole-body hyperthermia and antitumor agents. Lushnikova EL; Ovsyanko EV; Nepomnyashchikh LM; Efremov AV; Morozov DV Bull Exp Biol Med; 2011 Nov; 152(1):146-52. PubMed ID: 22803062 [TBL] [Abstract][Full Text] [Related]
3. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS]. Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study for the expression of Bcl-2 family proteins in Walker 256 carcinosarcoma cells under the influence of cytostatic drugs. Ovsjanko EV; Lushnikova EL; Larionov PM; Arkhipov SA; Nepomnyashchikh LM; Efremov AV; Ovsjanko YU Bull Exp Biol Med; 2009 Oct; 148(4):650-5. PubMed ID: 20396763 [TBL] [Abstract][Full Text] [Related]
5. Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells. Goel PN; Gude RP Biomed Pharmacother; 2014 Mar; 68(2):191-200. PubMed ID: 24373697 [TBL] [Abstract][Full Text] [Related]
6. Study of antitumor activity of antibodies to TNF-α on Walker carcinosarcoma model. Yurlova EI; Krylova SG; Dugina JL; Epstein OI Bull Exp Biol Med; 2013 Sep; 155(5):673-5. PubMed ID: 24288736 [TBL] [Abstract][Full Text] [Related]
7. Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone. Koch R; Aung T; Vogel D; Chapuy B; Wenzel D; Becker S; Sinzig U; Venkataramani V; von Mach T; Jacob R; Truemper L; Wulf GG Clin Cancer Res; 2016 Jan; 22(2):395-404. PubMed ID: 26369630 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effectiveness of mono- and polychemotherapy for murine lymphosarcoma, resistant to apoptosis induction]. Kaledin VI; Popova NA; Andreeva EM Vopr Onkol; 2006; 52(1):70-3. PubMed ID: 16715708 [TBL] [Abstract][Full Text] [Related]
9. Potentiated cyclophosphane: experimental study of the effect on tumor development and efficiency of cytostatic therapy. Amosova EN; Zueva EP; Razina TG; Krylova SG; Shilova NV; Epstein OI Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():107-10. PubMed ID: 12949669 [TBL] [Abstract][Full Text] [Related]
10. Curdlan derivatives able to enhance cytostatic drugs activity on tumor cells. Bădulescu MM; Apetrei NS; Lupu AR; Cremer L; Szegli G; Moscovici M; Mocanu G; Mihai D; Călugăru A Roum Arch Microbiol Immunol; 2009; 68(4):201-6. PubMed ID: 20583473 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab. Alas S; Bonavida B; Emmanouilides C Anticancer Res; 2000; 20(5A):2961-6. PubMed ID: 11062708 [TBL] [Abstract][Full Text] [Related]
14. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206 [TBL] [Abstract][Full Text] [Related]
16. OT-404, multi-targeted anti-cancer agent affecting tumor proliferation, chemo-resistance, and angiogenesis. Rebbaa A; Patil G; Yalcin M; Sudha T; Mousa SA Cancer Lett; 2013 May; 332(1):55-62. PubMed ID: 23348692 [TBL] [Abstract][Full Text] [Related]
17. L744,832 and Everolimus Induce Cytotoxic and Cytostatic Effects in Non-Hodgkin Lymphoma Cells. Mendes J; Gonçalves AC; Alves R; Jorge J; Pires A; Ribeiro A; Sarmento-Ribeiro AB Pathol Oncol Res; 2016 Apr; 22(2):301-9. PubMed ID: 26545383 [TBL] [Abstract][Full Text] [Related]
18. Effects of the chemotherapeutic agents for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome. Vaisheva F; Delbes G; Hales BF; Robaire B J Androl; 2007; 28(4):578-87. PubMed ID: 17409468 [TBL] [Abstract][Full Text] [Related]
19. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents. Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich LI; Shvets YV; Lukyanova NY; Todor IM; Tregubova NA; Naleskina LA Ukr Biochem J; 2016; 88(1):99-108. PubMed ID: 29227592 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis. Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]